Journal of Basic and Clinical Immunology

ISSN: ISSN
1758-2008 (Print )
1758-2016 (Electronic)

Journal of Basic and Clinical Immunology

Journal of Basic and Clinical Immunology (JBCI) aims to advance scientific understanding of the immune system by publishing high-quality research on both fundamental immunological mechanisms and clinical applications. The journal serves as a global platform for researchers, clinicians, and academicians to disseminate new findings in immunology, fostering interdisciplinary collaboration and innovation. By focusing on both basic and applied immunology, the journal contributes to the development of effective diagnostic, therapeutic, and preventive strategies for immune-related disorders.

The scope of the journal encompasses a wide range of topics, including innate and adaptive immunity, autoimmune and inflammatory diseases, immunodeficiencies, hypersensitivity reactions, tumor immunology, and immunotherapeutic interventions. Research on vaccine development, infectious disease immunology, and host-pathogen interactions is also central to the journal’s mission. Additionally, studies exploring novel immunological biomarkers, advancements in immunotherapy, and the role of immunology in transplantation and regenerative medicine are encouraged.

To ensure the highest research standards, the Journal of Basic and Clinical Immunology follows a rigorous double-blind peer-review process. Each submission undergoes thorough evaluation by subject matter experts, ensuring scientific credibility, ethical integrity, and innovation in the field. By providing an open-access platform for the dissemination of immunological research, the journal aims to enhance global health outcomes through improved understanding and management of immune system disorders.

Immunology:
Immunology is the branch of biomedical science that studies the immune system, its structure, functions, and disorders. It plays a crucial role in understanding how the body defends against infections, autoimmune diseases, and cancers. Advances in immunology have led to the development of vaccines, immunotherapies, and targeted treatments for various diseases. Research in this field continues to evolve, contributing to medical breakthroughs in disease prevention and treatment.

Autoimmune Diseases:
Autoimmune diseases occur when the immune system mistakenly attacks the body’s own cells and tissues. Conditions such as rheumatoid arthritis, lupus, and multiple sclerosis fall under this category. These diseases arise due to genetic predisposition, environmental triggers, and immune dysregulation. Advances in immunomodulatory therapies and biologics have significantly improved disease management, enhancing the quality of life for affected individuals.

Immunotherapy:
Immunotherapy refers to treatments that harness or modify the immune system to fight diseases such as cancer, autoimmune conditions, and infectious diseases. Techniques include checkpoint inhibitors, monoclonal antibodies, CAR-T cell therapy, and cytokine-based treatments. Immunotherapy has revolutionized oncology, offering promising alternatives to conventional treatments like chemotherapy and radiation.

Vaccines and Immunization:
Vaccines stimulate the immune system to develop immunity against infectious diseases. They work by exposing the body to an antigen, triggering an immune response without causing illness. Advances in vaccine research, including mRNA vaccines, have contributed to combating global health threats such as COVID-19, influenza, and HPV. Ongoing research focuses on developing universal vaccines and improving immunization coverage worldwide.

Tumor Immunology:
Tumor immunology explores how the immune system interacts with cancer cells. Some tumors evade immune detection by suppressing immune responses, allowing unchecked growth. Research in this field has led to the development of immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapies that boost immune responses against cancer. Understanding tumor immunology is essential for advancing personalized cancer treatments.

Allergy and Hypersensitivity:
Allergic reactions occur when the immune system overreacts to harmless substances, such as pollen, food, or insect venom. Hypersensitivity reactions are classified into four types, with IgE-mediated allergies being the most common. Treatments include antihistamines, immunotherapy (allergy shots), and biologic therapies targeting specific immune pathways. Research in allergy immunology aims to develop better diagnostic and therapeutic strategies for managing hypersensitivity disorders.

Journal Metrics:

Impact Factor 2.19
Scimago Journal Rank (SJR) 25
SJR Total Cites 20
Source Normalized Impact per Paper (SNIP) 14.82
h-index (2023) 40
PubMed NLM ID: 101558757
Google Scholar h5 index: 32
Iindex Copernicus Value: 119.6

Publons

Indexing Services